Keurig Dr Pepper (NASDAQ:KDP – Free Report) had its price objective trimmed by Barclays from $39.00 to $36.00 in a research note issued to investors on Friday morning,Benzinga reports.

Barclays lowered the firm’s price target on Keurig Dr Pepper (KDP) to $36 from $39 and keeps an Overweight rating on the shares as part of a consumer staples Q4 earnings preview. Put simply ...

In a report released today, Lauren Lieberman from Barclays maintained a Buy rating on Keurig Dr Pepper (KDP – Research Report), with a price target of $36.00. The company’s shares closed ...

We recently published a list of 12 Best FMCG Stocks To Buy According to Hedge Funds. In this article, we are going to take a ...

SG Americas Securities LLC lowered its stake in shares of Keurig Dr Pepper Inc. (NASDAQ:KDP – Free Report) by 40.2% in the ...

Keurig Dr Pepper Inc. (KDP), with a market cap of $43.5 billion, is a leading beverage company known for its diverse ...

Keurig Dr Pepper Inc. closed 17.55% short of its 52-week high of $38.28, which the company reached on September 24th.

Burlington, Mass., and Frisco, Texas, unveiled its 2025 new flavor lineup in the U.S., featuring brands such as Dr Pepper, ...

The extension is the first permanent offering since Strawberries & Cream in 2023 and comes as its parent company launches ...